SAN DIEGO, May 19 Volcano Corporation(Nasdaq: VOLC), a provider of intravascular ultrasound (IVUS), functionalmeasurement (FM) and Optical Coherence Tomography (OCT) products designed toenhance the diagnosis and treatment of coronary and peripheral vasculardisease, said today that it will be participating in the Seventh Annual JMPSecurities Research Conference on Tuesday, May 20.
The presentation by Scott Huennekens, president and chief executiveofficer, will begin at 11:30 a.m., Pacific Daylight Time (2:30 p.m., EasternDaylight Time).
The presentation will be available through the conference website athttp://www.wsw.com/webcast/jmp6/volc/ or via the company's website athttp://www.volcanocorp.com.
Volcano Corporation (Nasdaq: VOLC) offers a broad suite of devicesdesigned to facilitate endovascular procedures, enhance the diagnosis ofvascular and structural heart disease and guide optimal therapies. Thecompany's intravascular ultrasound (IVUS) product line includes ultrasoundconsoles that can be integrated directly into virtually any modern cath lab.Volcano IVUS offers unique features, including both single-use phased arrayand rotational IVUS imaging catheters, and advanced functionality options,such as VH(TM) tissue characterization and ChromaFlo(R). Volcano also providesfunctional measurement (FM) consoles and single-use pressure and flow guidewires and is developing a line of ultra-high resolution Optical CoherenceTomography (OCT) systems and catheters. Currently, more than 3,300 VolcanoIVUS and FM systems are installed worldwide, with approximately half of itsrevenues coming from outside the United States. For more information, visitthe company's website at http://www.volcanocorp.com.
SOURCE Volcano Corporation